Dexcom reaffirms full-year forecast after topping quarterly estimates
April 30 (Reuters) - Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped by strong demand for its continuous glucose monitors that track blood sugar levels.
Shares of the company were down 4.3% in... Read More.


